Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity

This study is currently recruiting participants.
Verified February 2013 by Texas Woman's University
Sponsor:
Information provided by (Responsible Party):
Texas Woman's University
ClinicalTrials.gov Identifier:
NCT01637480
First received: June 25, 2012
Last updated: February 26, 2013
Last verified: February 2013

June 25, 2012
February 26, 2013
July 2012
May 2013   (final data collection date for primary outcome measure)
Electromyography (EMG) [ Time Frame: The EMG data will be collected within 48 hours for all participants in both groups. On Day 1, data will be collected twice at baseline. On Day 2, data will be collected before and immediately after as well as 15, 30, and 45 min after the intervention. ] [ Designated as safety issue: No ]
Electromyography (EMG) onset time of the gluteus maximus, gluteus medius, vastus medialis oblique, and vastus lateralis muscles.
Same as current
Complete list of historical versions of study NCT01637480 on ClinicalTrials.gov Archive Site
Pain Visual Analog Scale (VAS) [ Time Frame: The Pain Visual Analog Scale (VAS) will be assessed before and 45 min after the lower back treatment (lumbopelvic manipulation) for participants in the patellofemoral pain syndrome group on Day 2 only. ] [ Designated as safety issue: No ]
Pain Visual Analog Scale (VAS) is a 100 mm continuous line between two end-points. The left end-point represents "no pain" and the right end-point represents the "worst pain imaginable".
Same as current
Not Provided
Not Provided
 
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome

The purpose of this study is to determined if a lower back treatment would change the hip and knee muscle activities in people with and without anterior knee pain. The investigators hypothesized that the lower back treatment may change the hip and knee muscle activities in people with anterior knee pain but not in people without anterior knee pain.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Patellofemoral Pain Syndrome
Other: Lumbopelvic manipulation
High-velocity-low-amplitude thrust manipulation of the lumbopelvic region
  • Experimental: Patellofemoral Pain Syndrome
    Participants with Patellofemoral Pain Syndrome
    Intervention: Other: Lumbopelvic manipulation
  • Active Comparator: Healthy control
    Age- and gender-matched participants without Patellofemoral Pain Syndrome
    Intervention: Other: Lumbopelvic manipulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
May 2013
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria for participants in the patellofemoral pain syndrome group:

  1. insidious onset of symptoms of non-traumatic origin
  2. pain with patellar facet palpation or compression
  3. subjective knee pain rating of at least 3/10 on the pain visual analog scale during at least one of the following activities:

    • ascending stair
    • descending stair
    • kneeling
    • squatting
    • running
    • jumping
    • prolong sitting for more than 20 minutes

Exclusion criteria for all participants:

  1. history of spine, hip or knee surgery
  2. history of hip pathology or other knee condition
  3. current significant injury of any lower extremity joints
  4. pregnancy
  5. sign of nerve root compression
  6. osteoporosis or history of compression fracture

Age- and gender- matched control participants will be recruited if they have no signs or symptoms of patellofemoral pain syndrome and have none of the exclusion criteria

Both
18 Years to 50 Years
Yes
Not Provided
United States
 
NCT01637480
16882
Yes
Texas Woman's University
Texas Woman's University
Not Provided
Principal Investigator: Ammar M Al Abbad, Master Texas Woman's University
Texas Woman's University
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP